The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
D000349:Africa; D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D002051:Burkitt Lymphoma / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000382:microbiology*; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002648:Child; D004279:DNA, Viral / Q000032:analysis; D003878:Dermatoglyphics; D004195:Disease Models, Animal; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000472:pathogenicity*; D006801:Humans; D007244:Infectious Mononucleosis / Q000209:etiology / Q000276:immunology; D008221:Lymphoid Tissue / Q000166:cytology; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis* / Q000209:etiology* / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D009374:Neoplasms, Experimental; D011379:Prognosis
D000914:Antibodies, Viral; D004279:DNA, Viral